Eric M Dube
Director, CHIEF EXECUTIVE OFFICER · 3 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | May 6, 2026 | Sale | $43.95 | 22,500 | $988.9K | 432,886 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | May 4, 2026 | Option Exercise | $0.00 | 22,500 | — | 455,386 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Apr 15, 2026 | Sale | $41.09 | 64,000 | $2.6M | 432,886 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Apr 13, 2026 | Grant/Award | $0.00 | 64,000 | — | 496,886 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | Sale | $30.93 | 60,000 | $1.9M | 432,886 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | Option Exercise | $15.46 | 60,000 | $927.6K | 492,886 |